Skip to main content
Erschienen in: BMC Anesthesiology 1/2023

Open Access 01.12.2023 | Research

ABO blood types may affect transient neurological events after surgical revascularization in patients with moyamoya disease: a retrospective single center study

verfasst von: Mei-Ping Qian, Mei-Rong Dong, Ming-Ming Han, Juan Li, Fang Kang

Erschienen in: BMC Anesthesiology | Ausgabe 1/2023

Abstract

Background

Moyamoya disease (MMD) is a cerebrovascular disease with unknown cause. Patients with MMD disease usually experience transient neurological events (TNEs) after revascularization surgery. This retrospective single-center study was aimed to explore the risk factors of postoperative TNEs after surgical revascularization in patients with MMD.

Methods

We selected 324 patients who underwent surgical revascularization between January 2017 and September 2022 in our center. The perioperative characteristics of the patients were recorded and the outcome was TNEs after surgery. An analysis of risk factors contributing to postoperative TNEs by using logistic regression model.

Results

Three hundred twelve patients were enrolled, and the incidence of postoperative TNEs was 34% in our study. Males were more likely to suffer from postoperative TNEs (OR = 2.344, p = 0.002). Preoperative ischemic presentation (OR = 1.849, p = 0.048) and intraoperative hypotension (OR = 2.332, p = 0.002) were associated with postoperative TNEs. Compared to patients with blood type O, patients with blood type A (OR = 2.325, p = 0.028), B (OR = 2.239, p = 0.027) and AB (OR = 2.938, p = 0.019) had a significantly higher incidence of postoperative TNEs. A risk prediction model for postoperative TNEs was established, and the established risk prediction area under the receiver operating characteristic curve (ROC) of the model was 0.741.

Conclusions

Males, preoperative ischemic presentation and intraoperative hypotension were associated with postoperative TNEs. We also found a possible link between postoperative TNEs and ABO blood types after surgical revascularization for moyamoya patients.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Background

Moyamoya disease (MMD) is a cerebrovascular disease with unknown cause. It is characterized by occlusion of the end and main branches of the internal carotid artery and often presents as intracranial hemorrhage, transient ischemic attacks or seizures [1, 2]. Compared with other treatments, surgical revascularization is the most effective treatment for MMD [3]. However, postoperative transient neurological events (TNEs) are usually occurred after surgical revascularization for MMD. Previous studies have indicated that the incidence of postoperative TNEs ranges from 15–67.1% [4, 5].
Postoperative complications are closely related to operation and anesthesia. Perioperative factors can affect intracranial hemodynamics in MMD patients, leading to new neurological complications in some patients after surgery [6]. The ABO blood group system is one of the most important systems known in humans that is used in clinical transfusion [7]. Previous research has shown that ABO blood types are correlated with many clinical conditions, including pain perception, diverse cancers, and cardiovascular diseases [810]. In a study [11] on the relationship between ABO blood type and delayed cerebral ischemia onset after aneurysmal subarachnoid hemorrhage, Researchers have found that blood type may be associated with cerebral vasospasm. Bypass vessels vasospasm can affect the perfusion of brain tissue and may lead to the occurrence of postoperative TNEs in patients with moyamoya disease. However, the relationship between blood type and TNEs after revascularization surgery for patients with MMD has not been reported. The aim of this retrospective single-center study was to identify the risk factors of postoperative TNEs after surgical revascularization in patients with MMD.

Materials and methods

Ethics and patients

This study was permitted by the Clinical Research Ethics Committee of The First Affiliated Hospital of University of Science and Technology of China, Anhui, China (2022-RE-352, Chairperson Prof. Zuojun Shen). Due to the non-interventional study design, the Institutional Review Board of The First Affiliated Hospital of University of Science and Technology of China waived the need for written informed consent from participants. This study was performed in accordance with the Declaration of Helsinki and with the STROBE Statement. The revascularization surgery was performed by the same neurosurgeon in our center between January 2017 and September 2022. Only patients with a confirmed diagnosis of MMD by preoperative diagnostic cerebral angiography were included in this study. We retrospectively reviewed the medical records of patients with Moyamoya disease older than 18 years who underwent a combined bypass of superficial temporal artery-middle cerebral artery (STA-MCA) anastomosis and encephalo-duro-arterio-synangiosis. Patients with missing data were excluded from the study.

Methods and data acquisition

After entering the room, the patient underwent invasive arterial pressure measurement. All patients underwent general anesthesia with midazolam (0.02 mg/kg), etomidate (0.2 mg/kg), sufentanil (0.5 µg/kg), and cisatracurium (0.2 mg/kg) for induction and propofol (6 to 8 mg/kg/h), remifentanil (0.1–0.3 µg/kg/min) and sevoflurane (up to 0.5MAC) for maintenance. During the operation, the blood pressure was maintained above the preoperatively measured blood pressure (vasoactive drugs were used when necessary). A normal CO2 level (35–45 mm Hg) was maintained throughout surgery. Data were obtained by retrospectively reviewing records maintained in our institution. Patient demographic information, preoperative comorbidities, clinical features, preoperative imaging, preoperative laboratory data, intraoperative factors, postoperative results and laboratory data were recorded. The outcome was the occurrence of postoperative TNEs. The evaluation period for TNEs was the first 24 h postoperatively. Postoperative TNEs were defined as the appearance of transient neurological symptoms (lasting < 24 h) as previous literature [12, 13]. The episodes of neurological dysfunction as follows: (1) no sign of cerebral infarction or acute cerebral hemorrage in radiological images; (2) any reversible neurological defects (e.g., number) recognized subjectively by the patients; (3) any reversible neurological defects (e.g., hemiparesis, dysarthria) observed objectively by the doctors.

Postoperative management and clinical follow-up

After extubation, patients were transferred to the neurosurgery intensive care unit (NICU). After the operation, blood pressure was maintained at the baseline level. Postoperative CT scan was routinely performed to identify hemorrhagic or infarction on the first postoperative day. Perform head CT-CTA assessment on patients with postoperative TNEs to rule out hemorrhagic events and confirm bypass patency. All patients should avoid the occurrence of hypovolemia and hypotension, and aspirin was administered for patients with ischemic-type MMD at the first day after surgery. Patients were given improve circulation drugs and resisting vasospasm drugs to relieve the symptoms of postoperative TNEs. Patients were clinically evaluated at discharge and after three months follow-up. Clinical follow up angiography was conducted 3 months postoperatively to evaluate the patency of the bypass vessel.

Statistical analysis

The normal distribution test was checked in the continuous variables using Shapiro test. Continuous variables are expressed as the mean ± SD, and categorical variables are reported as counts with percentages. T-test or Mann‒Whitney test was used to test for differences between continuous variables. Chi-square test or Fisher’s exact test was used to compare the proportions of categorical variables between groups. Based on various predictive variables, univariate and multivariable logistic regressions were performed with postoperative TNEs as the outcome variable. A predictor variable was included in the multivariable model if p < 0.15. Statistically significant differences between groups were indicated by a P value < 0.05. The receiver operating characteristic (ROC) curve and the area under the curve (AUC) were calculated.
All significance tests were two-sided and p value less than 0.05 was considered as statistically significant. Tukey method was used for post-hoc multiple comparisons testing when needed. SAS version 9.4 (SAS Institute Inc.) was used for all analyses.

Results

Three hundred twenty-four patients who underwent unilateral surgical revascularization were included in this study, and 12 patients were excluded (Fig. 1). The incidence of postoperative TNEs was 34% (n = 106). Table 1 shows the perioperative characteristics of the patients in each group. There was significantly statistical difference between the two groups in the age, proportion of male patients, preoperative hemoglobin, fasting blood glucose, preoperative stroke, onset symptoms, intraoperative hypotension (relative decrease in systolic blood pressure more than 20% from baseline) and postoperative hemoglobin (p < 0.05).
Table 1
Perioperative Characteristics of Patients with and without Postoperative TNEs (Transient Neurological Events)
Variable
Transient Neurological Events
p
 
All Patients n = 312
Yes, n = 106
No, n = 206
 
Age (y)
45.11 ± 9.96
43.14 ± 9.83
46.13 ± 9.89)
0.0119*
Male, n (%)
145(46.47)
63(59.43)
82(39.81)
0.001*
Body mass index (kg/m2)
24.2 ± 2.85
24.24 ± 2.96
24.19 ± 2.81
0.8849
Preoperative platelets(10^9/L)
190.13 ± 56.59
184.79 ± 54.09
192.88 ± 57.76
0.2325
Preoperative Hemoglobin (g/dL)
129.32 ± 14.18
132.68 ± 14.57
127.59 ± 13.69
0.0026*
Preoperative NA+(mmol/L)
141.4 ± 1.94
141.47 ± 1.92
141.36 ± 1.95
0.6434
Fasting blood glucose(mmol/L)
4.86 ± 0.88
4.73 ± 0.74
4.93 ± 0.94
0.0376*
Comorbidities, n (%)
    
Hypertension
112 (35.9)
33 (31.13)
79 (38.35)
0.2081
Diabetes
19 (6.09)
4 (3.77)
15 (7.28)
0.2198
Stroke
39 (12.5)
19 (17.92)
20 (9.71)
0.0377*
Blood types, n (%)
   
0.0591
O
82 (26.28)
18 (16.98)
64 (31.07)
 
A
86 (27.56)
33 (31.13)
53 (25.73)
 
B
103 (33.01)
38 (35.85)
65 (31.55)
 
AB
41 (13.14)
17 (16.04)
24 (11.65)
 
Preoperative albumin(g/L)
40 ± 2.86
40.23 ± 2.99
39.88 ± 2.79
0.3008
Onset symptoms, n (%)
   
0.0463*
Ischemic
77(24.68)
35(33.02)
42(20.39)
 
Hemorrhagic
50 (16.03)
14 (13.21)
36(17.48)
 
Others
185 (59.29)
57(53.77)
128 (62.13)
 
Intraoperative hypotension, n (%)
103(33.01)
45(42.45)
58(28.16)
0.0120*
Angiographic Suzuki Grade#, n (%)
   
0.0897
Grade III
73 (23.4)
31 (29.25)
42 (20.39)
 
Grade IV
64 (20.51)
26 (24.53)
38 (18.45)
 
Grade V
118 (37.82)
34 (32.08)
84 (40.78)
 
Grade VI
57 (18.27)
15 (14.15)
42 (20.39)
 
Duration of surgery(min)
341.34 ± 53.15
342.87 ± 53.66
340.55 ± 53
0.7163
Duration of anesthesia(min)
387.43 ± 52.39
388.84 ± 50.69
386.7 ± 53.35
0.7337
Infusion volume(ml)
4186.25 ± 1014.65
4191.98 ± 1090.68
4183.3 ± 975.98
0.9431
Postoperative Hemoglobin(g/dL)
111.58 ± 14.26
114.44 ± 14.16
110.1 ± 14.11
0.0106*
Postoperative platelets(10^9/L)
185.04 ± 50.96
185.35 ± 51.09
184.87 ± 51.02
0.938
Postoperative albumin(g/L)
33.13 ± 3.1
33.48 ± 3.34
32.95 ± 2.97
0.1508
Note: # Suzuki Grading System: Grade I: narrowing of ICA apex; grade II: initiation of moyamoya collaterals; grade III: progressive ICA stenosis with intensifification of moyamoya-associated collaterals; grade IV: development of ECA collaterals; grade V: intensifification of ECA collaterals and reduction of moyamoya-associated vessels; grade VI: total occlusion of ICA and disappearance of moyamoya-associated collaterals. * Indicates P < 0.05
In the regression model with TNEs as the outcome, only age, sex, fasting blood glucose, stroke status, blood type, onset symptoms, intraoperative hypotension and angiographic Suzuki grade were included in the final multivariate logistic regression. Males were more likely to suffer from postoperative TNEs (OR = 2.344,95% CI, 1.387, 3.961; p = 0.002). Preoperative ischemic presentation (OR = 1.849,95% CI, 1.005, 3.400; p = 0.048) and intraoperative hypotension (OR = 2.332, 95% CI, 1.350,4.030; p = 0.002) were associated with postoperative TNEs. Compared to patients with blood type O, patients with blood type B (OR = 2.239, 95% CI, 1.095, 4.580; p = 0.027), AB (OR = 2.938, 95% CI,1.197, 7.212; p = 0.019) and A (OR = 2.325, 95% CI, 1.096, 4.933; p = 0.028) had a significantly higher incidence of postoperative TNEs (Table 2). Blood types were still an independent risk factor for predicting postoperative TNEs with AUC = 0.741 (Fig. 2).
Table 2
Logistic Regression Analysis for Occurrence of Postoperative TNEs
Risk factors
Univariate logistic regression
Multivariable logistic regression
OR (95% CI)
p value
OR (95% CI)
p value
Age
0.970(0.947, 0.994)
0.013
0.979 (0.953, 1.006)
0.112
Male
2.215 (1.374, 3.571)
0.001
2.344(1.387, 3.961)
0.002*
BMI
1.006 (0.927, 1.092)
0.884
  
Preoperative platelets
0.997 (0.993, 1.002)
0.232
  
Preoperative Hemoglobin
1.026 (1.009, 1.044)
0.003
  
Preoperative NA+
1.029 (0.912, 1.162)
0.642
  
Fasting blood glucose
0.711 (0.499, 1.011)
0.058
0.715(0.498, 1.026)
0.068
Comorbidities
    
Hypertension
0.727 (0.442, 1.196)
0.209
  
Diabetes
0.499 (0.161, 1.544)
0.228
  
Stroke
2.031 (1.031, 3.999)
0.040
2.010 (0.917, 4.404)
0.081
Blood types
    
O
Reference
 
Reference
 
A
2.214 (1.122, 4.370)
0.022
2.325 (1.096, 4.933)
0.028*
B
2.079 (1.076, 4.016)
0.029
2.239 (1.095, 4.580)
0.027*
AB
2.519 (1.118, 5.673)
0.026
2.938 (1.197, 7.212)
0.019*
Preoperative albumin
1.044 (0.962, 1.134)
0.301
  
Onset symptoms
    
Others
Reference
 
Reference
 
Hemorrhagic
0.873 (0.437, 1.744)
0.701
1.024(0.484,2.167)
0.950
Ischemic
1.871(1.084, 3.232)
0.025
1.849(1.005, 3.400)
0.048*
Intraoperative hypotension
3.194(1.955, 5.218)
0.012
2.332(1.350, 4.030)
0.002*
Angiographic Suzuki Grade
    
Grade III
Reference
 
Reference
 
Grade IV
0.927 (0.469, 1.832)
0.827
1.247 (0.589,2.640)
0.563
Grade V
0.548 (0.297, 1.011)
0.054
0.552 (0.280,1.088)
0.086
Grade VI
0.484 (0.229, 1.025)
0.058
0.484 (0.214,1.098)
0.083
Duration of surgery
1.001 (0.996, 1.005)
0.715
  
Duration of anesthesia
1.001 (0.996, 1.005)
0.733
  
Infusion volume
1 (1, 1)
0.943
  
Postoperative hemoglobin
1.022 (1.005, 1.039)
0.012
  
Postoperative platelets
1 (0.996, 1.005)
0.938
  
Postoperative albumin
1.057 (0.98, 1.14)
0.151
  
* Indicates P < 0.05

Discussion

Transient neurological events are commonly observed after surgical revascularization for MMD patients [14]. Previous studies have shown that these events will last for 7–10 days, which will increase the duration of hospitalization and the healthcare-related cost [15, 16]. However, the cause of TNEs in patients with MMD undergoing bypass surgery is still unclear. Our data show that gender, preoperative ischemic presentation, intraoperative hypotension and blood types were the risk factors of postoperative TNEs after revascularization surgery for MMD patients. Males were more likely to suffer from postoperative TNEs in our study. The relationship between gender and postoperative neurological events in patients with MMD was unclear. Study [17] has shown that female was independent risk factors for postoperative TNEs. However, A study has found that there is no gender difference in postoperative neurological outcomes in MMD [18]. A possible explanation for this may be related to different sex ratios of the selected research subjects. The presence of transient ischemic attack [19] and preoperative ischemic presentation [20] were identified as predictors of postoperative neurological outcomes, and our results were consistent with these research conclusions. Patients with the presence of transient ischemic attack were sensitive to intraoperative hemodynamic fluctuations, leading to the occurrence of postoperative TNEs.
Although study [21] has shown that the effect of intraoperative hypotension on perioperative stroke is unclear. Some studies [22, 23] have shown that intraoperative hypotension can be harmful to cerebral blood flow (CBF). Patients with moyamoya disease may be more sensitive to changes in CBF [24]. Intraoperative hypotension can aggravate insufficient cerebral microcirculation perfusion. The occurrence of intraoperative hypotension may lead to transient neurological events. Study has shown that intraoperative blood pressure fluctuations were independent risk factors for postoperative infarction after revascularization surgery in patients with moyamoya disease [25]. we also found intraoperative hypertension was associated with postoperative TNEs. There is no universal definition of intraoperative hypotension. We defined hypotension as a 20% reduction from baseline, study [26] suggested that this may be more appropriate for patients with chronic hypertension. Although our definition of hypotension is applicable to most patients, relative hypotension in few patients may be underrecognized.
Our study found a correlation between ABO blood type and the incidence of TNEs after surgical revascularization in patients with moyamoya disease. The incidence of TNEs in patients with blood type O was obviously lower than that in patients with blood type A, B or AB in our study. Studies have shown that non-O blood type individuals have increased risks of peripheral vascular disease, venous thrombosis, coronary heart disease, cancer, and ischemic stroke [2731]. Differences in platelets, endothelial cells and coagulation factors among patients with different blood types may be the cause of this phenomenon [32, 33].
Genetic factors may be the reason that blood type is related to the incidence of postoperative TNEs. ABO blood groups are determined by the ABO gene [34]. As a genetic marker, the ABO blood group antigen is inherited and expressed in a wide variety of human cells and tissues, such as platelets, endothelial cells and sensory neurons [35, 36]. Some studies [37, 38] have shown that peripheral vasospasm is related to increased levels of VIII factor. Compared with other blood types, plasma levels of von Willebrand factor (vWF) and factor VIII were significantly decreased in patients with blood type O [39]. Low levels of factor VIII and vWF might be the reason for the relatively low incidence of postoperative TNEs after surgical revascularization for MMD patients with blood type O.
Nitric oxide (NO) regulates regional cerebral blood flow and correlates with the occurrence of ischemia [40, 41]. Studies [42] have shown that the reduction of contents of NO can inhibit endothelium-dependent vasodilatation function, leading to cerebral vasospasm. Nitric oxide (NO) regulates regional cerebral blood flow and correlates with the occurrence of ischemia [40, 41]. Studies [42] have shown that the reduction of contents of NO can inhibit endothelium-dependent vasodilatation function, leading to cerebral vasospasm. Local cortical hyperperfusion and watershed shift caused by vasospasm after surgical revascularization might be the cause of postoperative TNEs [43, 44]. NO may play a role in regulating the occurrence of vasospasm after revascularization surgery for MMD. Individuals with blood type B or AB were significantly less responsive to NO than individuals with blood type O or A [45]. NO reaction may be another reason for the relatively low incidence of TNEs in patients with blood type O compared with others.
There were several limitations in our study. First, our study was based on single center results, so selection bias is possible. Second, the study included an unequal distribution of patients with different blood types, which may have affected the results. Third, although many clinical factors were recorded in our study, the changes of postoperative blood pressure and other unknown confounders were not analyzed in this study. Last, Hemodynamic studies were mandatory to discuss TNEs after revascularization surgery for MMD. It remains uncertain which types of hemodynamic changes (hyperperfusion, hypoperfusion, watershed shift, and so on) result from ABO blood type. Further studies are required to verify which hemodynamic changes are affected by ABO blood type after surgical revascularization for Moyamoya disease.

Conclusion

The incidence of postoperative TNEs was 34% in our study. Males, preoperative ischemic presentation, intraoperative hypotension were risk factors for postoperative TNEs. We also found a possible link between postoperative TNEs and ABO blood types after surgical revascularization for moyamoya patients.

Acknowledgements

All coauthors of this work are very grateful to the clinical staff at the Department of Anaesthesiology, The First Affiliated Hospital of USTC, Hefei, Anhui, China, for their support and kind help.

Declarations

This study was permitted by the Clinical Research Ethics Committee of The First Affiliated Hospital of University of Science and Technology of China, Anhui, China (2022-RE-352, Chairperson Prof. Zuojun Shen). Due to the non-interventional study design, the Institutional Review Board of The First Affiliated Hospital of University of Science and Technology of China waived the need for written informed consent from participants. This study was performed in accordance with the Declaration of Helsinki and with the STROBE Statement.
Not applicable.

Competing interests

We declare that we have no conflicts of interest to this work.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Kuroda S, Houkin K. Moyamoya Disease: current concepts and future perspectives. Lancet Neurol. 2008;7(11):1056–66.PubMedCrossRef Kuroda S, Houkin K. Moyamoya Disease: current concepts and future perspectives. Lancet Neurol. 2008;7(11):1056–66.PubMedCrossRef
3.
Zurück zum Zitat Lee S, Yun TJ, Yoo RE, Yoon BW, Kang KM, Choi SH, Kim JH, Kim JE, Sohn CH, Han MH. Monitoring cerebral perfusion changes after revascularization in patients with Moyamoya Disease by using arterial spin-labeling MR Imaging. Radiology. 2018;288(2):565–72.PubMedCrossRef Lee S, Yun TJ, Yoo RE, Yoon BW, Kang KM, Choi SH, Kim JH, Kim JE, Sohn CH, Han MH. Monitoring cerebral perfusion changes after revascularization in patients with Moyamoya Disease by using arterial spin-labeling MR Imaging. Radiology. 2018;288(2):565–72.PubMedCrossRef
4.
Zurück zum Zitat Lotzke H, Jakobsson M, Brisby H, Gutke A, Hägg O, Smeets R, den Hollander M, Olsson LE, Lundberg M. Use of the PREPARE (PREhabilitation, physical activity and exeRcisE) program to improve outcomes after lumbar fusion Surgery for severe low back pain: a study protocol of a person-centred randomised controlled trial. BMC Musculoskelet Disord. 2016;17(1):349.PubMedPubMedCentralCrossRef Lotzke H, Jakobsson M, Brisby H, Gutke A, Hägg O, Smeets R, den Hollander M, Olsson LE, Lundberg M. Use of the PREPARE (PREhabilitation, physical activity and exeRcisE) program to improve outcomes after lumbar fusion Surgery for severe low back pain: a study protocol of a person-centred randomised controlled trial. BMC Musculoskelet Disord. 2016;17(1):349.PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Hayashi K, Horie N, Suyama K, Nagata I. Incidence and clinical features of symptomatic cerebral hyperperfusion Syndrome after Vascular Reconstruction. World Neurosurg. 2012;78(5):447–54.PubMedCrossRef Hayashi K, Horie N, Suyama K, Nagata I. Incidence and clinical features of symptomatic cerebral hyperperfusion Syndrome after Vascular Reconstruction. World Neurosurg. 2012;78(5):447–54.PubMedCrossRef
6.
Zurück zum Zitat Kazumata K, Ito M, Tokairin K, Ito Y, Houkin K, Nakayama N, Kuroda S, Ishikawa T, Kamiyama H. The frequency of postoperative Stroke in moyamoya Disease following combined revascularization: a single-university series and systematic review. J Neurosurg. 2014;121(2):432–40.PubMedCrossRef Kazumata K, Ito M, Tokairin K, Ito Y, Houkin K, Nakayama N, Kuroda S, Ishikawa T, Kamiyama H. The frequency of postoperative Stroke in moyamoya Disease following combined revascularization: a single-university series and systematic review. J Neurosurg. 2014;121(2):432–40.PubMedCrossRef
7.
Zurück zum Zitat Garvert L, Baune BT, Berger K, Boomsma DI, Breen G, Greinacher A, Hamilton SP, Levinson DF, Lewis CM, Lucae S et al. The association between genetically determined ABO blood types and major depressive disorder. Psychiatry Res. 2021;299. Garvert L, Baune BT, Berger K, Boomsma DI, Breen G, Greinacher A, Hamilton SP, Levinson DF, Lewis CM, Lucae S et al. The association between genetically determined ABO blood types and major depressive disorder. Psychiatry Res. 2021;299.
8.
Zurück zum Zitat Simoni AH, Jerwiarz A, Randers A, Gazerani P. Association between ABO blood types and pain perception. Somatosens Mot Res. 2017;34(4):258–64.PubMedCrossRef Simoni AH, Jerwiarz A, Randers A, Gazerani P. Association between ABO blood types and pain perception. Somatosens Mot Res. 2017;34(4):258–64.PubMedCrossRef
9.
Zurück zum Zitat Franchini M, Liumbruno GM, Lippi G. The prognostic value of ABO blood group in cancer patients. Blood Transfus. 2016;14(5):434–40.PubMedPubMedCentral Franchini M, Liumbruno GM, Lippi G. The prognostic value of ABO blood group in cancer patients. Blood Transfus. 2016;14(5):434–40.PubMedPubMedCentral
10.
Zurück zum Zitat Zhang H, Mooney CJ, Reilly MP. ABO Blood groups and Cardiovascular Diseases. Int J Vascular Med. 2012;2012:641917–7.CrossRef Zhang H, Mooney CJ, Reilly MP. ABO Blood groups and Cardiovascular Diseases. Int J Vascular Med. 2012;2012:641917–7.CrossRef
11.
Zurück zum Zitat Unda SR, Vats T, Garza RDL, Cezaryirli P, Altschul DJ. Role of ABO blood type in delayed cerebral ischemia onset and clinical outcomes after aneurysmal subarachnoid Hemorrhage in an ethnic minority urban population. Surg Neurol Int. 2020;11:108–8.PubMedPubMedCentralCrossRef Unda SR, Vats T, Garza RDL, Cezaryirli P, Altschul DJ. Role of ABO blood type in delayed cerebral ischemia onset and clinical outcomes after aneurysmal subarachnoid Hemorrhage in an ethnic minority urban population. Surg Neurol Int. 2020;11:108–8.PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Hamano E, Kataoka H, Morita N, Maruyama D, Satow T, Iihara K, Takahashi JC. Clinical implications of the cortical hyperintensity belt sign in fluid-attenuated inversion recovery images after bypass Surgery for moyamoya Disease. J Neurosurg. 2017;126(1):1–7.PubMedCrossRef Hamano E, Kataoka H, Morita N, Maruyama D, Satow T, Iihara K, Takahashi JC. Clinical implications of the cortical hyperintensity belt sign in fluid-attenuated inversion recovery images after bypass Surgery for moyamoya Disease. J Neurosurg. 2017;126(1):1–7.PubMedCrossRef
13.
Zurück zum Zitat Egashira Y, Yamauchi K, Enomoto Y, Nakayama N, Yoshimura S, Iwama T. Disruption of Cortical Arterial Network is Associated with the severity of transient neurologic events after direct bypass Surgery in adult Moyamoya Disease. World Neurosurg. 2017;100:311–5.PubMedCrossRef Egashira Y, Yamauchi K, Enomoto Y, Nakayama N, Yoshimura S, Iwama T. Disruption of Cortical Arterial Network is Associated with the severity of transient neurologic events after direct bypass Surgery in adult Moyamoya Disease. World Neurosurg. 2017;100:311–5.PubMedCrossRef
14.
Zurück zum Zitat Fujimura M, Kaneta T, Mugikura S, Shimizu H, Tominaga T. Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya Disease. Surg Neurol. 2007;67(3):273–82.PubMedCrossRef Fujimura M, Kaneta T, Mugikura S, Shimizu H, Tominaga T. Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya Disease. Surg Neurol. 2007;67(3):273–82.PubMedCrossRef
15.
Zurück zum Zitat Fujimura M, Shimizu H, Mugikura S, Tominaga T. Delayed intracerebral Hemorrhage after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya Disease: possible involvement of cerebral hyperperfusion and increased vascular permeability. Surg Neurol. 2009;71(2):223–7. discussion 227.PubMedCrossRef Fujimura M, Shimizu H, Mugikura S, Tominaga T. Delayed intracerebral Hemorrhage after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya Disease: possible involvement of cerebral hyperperfusion and increased vascular permeability. Surg Neurol. 2009;71(2):223–7. discussion 227.PubMedCrossRef
16.
Zurück zum Zitat Ogasawara K, Komoribayashi N, Kobayashi M, Fukuda T, Inoue T, Yamadate K, Ogawa A. Neural damage caused by cerebral hyperperfusion after arterial bypass Surgery in a patient with moyamoya Disease: case report. Neurosurgery. 2005;56(6):E1380. discussion E1380.PubMedCrossRef Ogasawara K, Komoribayashi N, Kobayashi M, Fukuda T, Inoue T, Yamadate K, Ogawa A. Neural damage caused by cerebral hyperperfusion after arterial bypass Surgery in a patient with moyamoya Disease: case report. Neurosurgery. 2005;56(6):E1380. discussion E1380.PubMedCrossRef
17.
Zurück zum Zitat Lu J, Zhao Y, Ma L, Chen Y, Li M, Chen X, Ye X, Wang R, Zhao Y. Predictors and clinical features of transient neurological events after combined bypass revascularization for moyamoya Disease. Clin Neurol Neurosurg. 2019;186:105505.PubMedCrossRef Lu J, Zhao Y, Ma L, Chen Y, Li M, Chen X, Ye X, Wang R, Zhao Y. Predictors and clinical features of transient neurological events after combined bypass revascularization for moyamoya Disease. Clin Neurol Neurosurg. 2019;186:105505.PubMedCrossRef
18.
Zurück zum Zitat Khan N, Achrol AS, Guzman R, Burns TC, Dodd R, Bell-Stephens T, Steinberg GK. Sex differences in clinical presentation and treatment outcomes in Moyamoya Disease. Neurosurgery. 2012;71(3):587–93.PubMedCrossRef Khan N, Achrol AS, Guzman R, Burns TC, Dodd R, Bell-Stephens T, Steinberg GK. Sex differences in clinical presentation and treatment outcomes in Moyamoya Disease. Neurosurgery. 2012;71(3):587–93.PubMedCrossRef
19.
Zurück zum Zitat Bao XY, Duan L, Li DS, Yang WZ, Sun WJ, Zhang ZS, Zong R, Han C. Clinical features, Surgical Treatment and Long-Term Outcome in Adult patients with Moyamoya Disease in China. Cerebrovasc Dis. 2012;34(4):305–13.PubMedCrossRef Bao XY, Duan L, Li DS, Yang WZ, Sun WJ, Zhang ZS, Zong R, Han C. Clinical features, Surgical Treatment and Long-Term Outcome in Adult patients with Moyamoya Disease in China. Cerebrovasc Dis. 2012;34(4):305–13.PubMedCrossRef
20.
Zurück zum Zitat Zhao M, Deng XF, Zhang D, Wang S, Zhang Y, Wang R, Zhao JZ. Risk factors for and outcomes of postoperative Complications in adult patients with moyamoya Disease. J Neurosurg. 2019;130(2):531–42.CrossRef Zhao M, Deng XF, Zhang D, Wang S, Zhang Y, Wang R, Zhao JZ. Risk factors for and outcomes of postoperative Complications in adult patients with moyamoya Disease. J Neurosurg. 2019;130(2):531–42.CrossRef
21.
Zurück zum Zitat Wongtangman K, Wachtendorf LJ, Blank M, Grabitz SD, Linhardt FC, Azimaraghi O, Raub D, Pham S, Kendale SM, Low YH, et al. Effect of intraoperative arterial hypotension on the risk of Perioperative Stroke after noncardiac Surgery: a retrospective Multicenter Cohort Study. Anesth Analg. 2021;133(4):1000–8.PubMedCrossRef Wongtangman K, Wachtendorf LJ, Blank M, Grabitz SD, Linhardt FC, Azimaraghi O, Raub D, Pham S, Kendale SM, Low YH, et al. Effect of intraoperative arterial hypotension on the risk of Perioperative Stroke after noncardiac Surgery: a retrospective Multicenter Cohort Study. Anesth Analg. 2021;133(4):1000–8.PubMedCrossRef
22.
Zurück zum Zitat Gregory A, Stapelfeldt WH, Khanna AK, Smischney NJ, Boero IJ, Chen QY, Stevens M, Shaw AD. Intraoperative hypotension is Associated with adverse clinical outcomes after noncardiac Surgery. Anesth Analg. 2021;132(6):1654–65.PubMedCrossRef Gregory A, Stapelfeldt WH, Khanna AK, Smischney NJ, Boero IJ, Chen QY, Stevens M, Shaw AD. Intraoperative hypotension is Associated with adverse clinical outcomes after noncardiac Surgery. Anesth Analg. 2021;132(6):1654–65.PubMedCrossRef
23.
Zurück zum Zitat Bijker JB, Persoon S, Peelen LM, Moons KGM, Kalkman CJ, Kappelle LJ, van Klei WA. Intraoperative Hypotension and perioperative ischemic Stroke after general Surgery a nested case-control study. Anesthesiology. 2012;116(3):658–64.PubMedCrossRef Bijker JB, Persoon S, Peelen LM, Moons KGM, Kalkman CJ, Kappelle LJ, van Klei WA. Intraoperative Hypotension and perioperative ischemic Stroke after general Surgery a nested case-control study. Anesthesiology. 2012;116(3):658–64.PubMedCrossRef
24.
Zurück zum Zitat Kim SH, Choi JU, Yang KH, Kim TG, Kim DS. Risk factors for postoperative ischemic Complications in patients with moyamoya Disease. J Neurosurg. 2005;103(5):433–8.PubMed Kim SH, Choi JU, Yang KH, Kim TG, Kim DS. Risk factors for postoperative ischemic Complications in patients with moyamoya Disease. J Neurosurg. 2005;103(5):433–8.PubMed
25.
Zurück zum Zitat Li JX, Zhao YH, Zhao M, Cao PH, Liu XJ, Ren H, Zhang D, Zhang Y, Wang R, Zhao JZ. High variance of intraoperative blood pressure predicts early cerebral infarction after revascularization Surgery in patients with Moyamoya Disease. Neurosurg Rev. 2020;43(2):759–69.PubMedCrossRef Li JX, Zhao YH, Zhao M, Cao PH, Liu XJ, Ren H, Zhang D, Zhang Y, Wang R, Zhao JZ. High variance of intraoperative blood pressure predicts early cerebral infarction after revascularization Surgery in patients with Moyamoya Disease. Neurosurg Rev. 2020;43(2):759–69.PubMedCrossRef
26.
Zurück zum Zitat Meng L, Yu W, Wang T, Zhang L, Heerdt PM, Gelb AW. Blood pressure targets in Perioperative Care. Hypertens (Dallas Tex: 1979). 2018;72(4):806–17.CrossRef Meng L, Yu W, Wang T, Zhang L, Heerdt PM, Gelb AW. Blood pressure targets in Perioperative Care. Hypertens (Dallas Tex: 1979). 2018;72(4):806–17.CrossRef
27.
Zurück zum Zitat Goumidi L, Thibord F, Wiggins KL, Li-Gao RF, Brown MR, Vlieg AV, Souto JC, Soria JM, Ibrahim-Kosta M, Saut N, et al. Association between ABO haplotypes and the risk of venous Thrombosis: impact on Disease risk estimation. Blood. 2021;137(17):2394–402.PubMedPubMedCentralCrossRef Goumidi L, Thibord F, Wiggins KL, Li-Gao RF, Brown MR, Vlieg AV, Souto JC, Soria JM, Ibrahim-Kosta M, Saut N, et al. Association between ABO haplotypes and the risk of venous Thrombosis: impact on Disease risk estimation. Blood. 2021;137(17):2394–402.PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Tirado I, Mateo J, Soria JM, Oliver A, Martínez-Sánchez E, Vallvé C, Borrell M, Urrutia T, Fontcuberta J. The ABO blood group genotype and factor VIII levels as Independent risk factors for venous thromboembolism. Thromb Haemost. 2005;93(3):468–74.PubMedCrossRef Tirado I, Mateo J, Soria JM, Oliver A, Martínez-Sánchez E, Vallvé C, Borrell M, Urrutia T, Fontcuberta J. The ABO blood group genotype and factor VIII levels as Independent risk factors for venous thromboembolism. Thromb Haemost. 2005;93(3):468–74.PubMedCrossRef
29.
Zurück zum Zitat He M, Wolpin B, Rexrode K, Manson JE, Rimm E, Hu FB, Qi L. ABO blood group and risk of coronary Heart Disease in two prospective cohort studies. Arterioscler Thromb Vasc Biol. 2012;32(9):2314–20.PubMedPubMedCentralCrossRef He M, Wolpin B, Rexrode K, Manson JE, Rimm E, Hu FB, Qi L. ABO blood group and risk of coronary Heart Disease in two prospective cohort studies. Arterioscler Thromb Vasc Biol. 2012;32(9):2314–20.PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Jacobs EJ, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to Pancreatic cancer. Nat Genet. 2009;41(9):986–90.PubMedPubMedCentralCrossRef Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Jacobs EJ, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to Pancreatic cancer. Nat Genet. 2009;41(9):986–90.PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Jaworek T, Xu H, Gaynor BJ, Cole JW, Rannikmae K, Stanne TM, Tomppo L, Abedi V, Amouyel P, Armstrong ND, et al. Contribution of common genetic variants to risk of early onset ischemic Stroke. Neurology. 2022;99(16):e1738–1754.PubMedPubMedCentralCrossRef Jaworek T, Xu H, Gaynor BJ, Cole JW, Rannikmae K, Stanne TM, Tomppo L, Abedi V, Amouyel P, Armstrong ND, et al. Contribution of common genetic variants to risk of early onset ischemic Stroke. Neurology. 2022;99(16):e1738–1754.PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Jenkins PV, O’Donnell JS. ABO blood group determines plasma von Willebrand factor levels: a biologic function after all? Transfusion. 2006;46(10):1836–44.PubMedCrossRef Jenkins PV, O’Donnell JS. ABO blood group determines plasma von Willebrand factor levels: a biologic function after all? Transfusion. 2006;46(10):1836–44.PubMedCrossRef
33.
Zurück zum Zitat Gallinaro L, Cattini MG, Sztukowska M, Padrini R, Sartorello F, Pontara E, Bertomoro A, Daidone V, Pagnan A, Casonato A. A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor. Blood. 2008;111(7):3540–5.PubMedCrossRef Gallinaro L, Cattini MG, Sztukowska M, Padrini R, Sartorello F, Pontara E, Bertomoro A, Daidone V, Pagnan A, Casonato A. A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor. Blood. 2008;111(7):3540–5.PubMedCrossRef
34.
Zurück zum Zitat Yamamoto F, Clausen H, White T, Marken J, Hakomori S. Molecular genetic basis of the histo-blood group ABO system. Nature. 1990;345(6272):229–33.PubMedCrossRef Yamamoto F, Clausen H, White T, Marken J, Hakomori S. Molecular genetic basis of the histo-blood group ABO system. Nature. 1990;345(6272):229–33.PubMedCrossRef
35.
Zurück zum Zitat Franchini M, Liumbruno GM. ABO blood group: old dogma, new perspectives. Clin Chem Lab Med. 2013;51(8):1545–53.PubMedCrossRef Franchini M, Liumbruno GM. ABO blood group: old dogma, new perspectives. Clin Chem Lab Med. 2013;51(8):1545–53.PubMedCrossRef
36.
Zurück zum Zitat Liumbruno GM, Franchini M. Beyond immunohaematology: the role of the ABO blood group in human Diseases. Blood Transfus = Trasfusione del sangue. 2013;11(4):491–9.PubMed Liumbruno GM, Franchini M. Beyond immunohaematology: the role of the ABO blood group in human Diseases. Blood Transfus = Trasfusione del sangue. 2013;11(4):491–9.PubMed
37.
Zurück zum Zitat Zhang H, Mooney CJ, Reilly MP. ABO Blood groups and Cardiovascular Diseases. Int J Vascular Med. 2012;2012:641917.CrossRef Zhang H, Mooney CJ, Reilly MP. ABO Blood groups and Cardiovascular Diseases. Int J Vascular Med. 2012;2012:641917.CrossRef
38.
Zurück zum Zitat Zabaneh D, Gaunt TR, Kumari M, Drenos F, Shah S, Berry D, Power C, Hypponen E, Shah T, Palmen J, et al. Genetic variants associated with Von Willebrand factor levels in healthy men and women identified using the HumanCVD BeadChip. Ann Hum Genet. 2011;75(4):456–67.PubMedCrossRef Zabaneh D, Gaunt TR, Kumari M, Drenos F, Shah S, Berry D, Power C, Hypponen E, Shah T, Palmen J, et al. Genetic variants associated with Von Willebrand factor levels in healthy men and women identified using the HumanCVD BeadChip. Ann Hum Genet. 2011;75(4):456–67.PubMedCrossRef
39.
Zurück zum Zitat O’Donnell J, Laffan MA. The relationship between ABO histo-blood group, factor VIII and Von Willebrand factor. Transfus Med. 2001;11(4):343–51.PubMedCrossRef O’Donnell J, Laffan MA. The relationship between ABO histo-blood group, factor VIII and Von Willebrand factor. Transfus Med. 2001;11(4):343–51.PubMedCrossRef
40.
Zurück zum Zitat Castillo J, Rama R, Davalos A. Nitric oxide-related brain damage in acute ischemic Stroke. Stroke. 2000;31(4):852–7.PubMedCrossRef Castillo J, Rama R, Davalos A. Nitric oxide-related brain damage in acute ischemic Stroke. Stroke. 2000;31(4):852–7.PubMedCrossRef
41.
Zurück zum Zitat Rifkind JM, Nagababu E, Barbiro-Michaely E, Ramasamy S, Pluta RM, Mayevsky A. Nitrite infusion increases cerebral blood flow and decreases mean arterial blood pressure in rats: a role for red cell NO. Nitric Oxide: Biology and Chemistry. 2007;16(4):448–56.PubMedCrossRef Rifkind JM, Nagababu E, Barbiro-Michaely E, Ramasamy S, Pluta RM, Mayevsky A. Nitrite infusion increases cerebral blood flow and decreases mean arterial blood pressure in rats: a role for red cell NO. Nitric Oxide: Biology and Chemistry. 2007;16(4):448–56.PubMedCrossRef
42.
Zurück zum Zitat Vellimana AK, Milner E, Azad TD, Harries MD, Zhou ML, Gidday JM, Han BH, Zipfel GJ. Endothelial nitric oxide synthase mediates endogenous protection against subarachnoid hemorrhage-induced cerebral vasospasm. Stroke. 2011;42(3):776–82.PubMedCrossRef Vellimana AK, Milner E, Azad TD, Harries MD, Zhou ML, Gidday JM, Han BH, Zipfel GJ. Endothelial nitric oxide synthase mediates endogenous protection against subarachnoid hemorrhage-induced cerebral vasospasm. Stroke. 2011;42(3):776–82.PubMedCrossRef
43.
Zurück zum Zitat Mukerji N, Cook DJ, Steinberg GK. Is local hypoperfusion the reason for transient neurological deficits after STA-MCA bypass for moyamoya Disease? J Neurosurg. 2015;122(1):90–4.PubMedCrossRef Mukerji N, Cook DJ, Steinberg GK. Is local hypoperfusion the reason for transient neurological deficits after STA-MCA bypass for moyamoya Disease? J Neurosurg. 2015;122(1):90–4.PubMedCrossRef
44.
Zurück zum Zitat Hayashi T, Shirane R, Fujimura M, Tominaga T. Postoperative neurological deterioration in pediatric moyamoya Disease: watershed shift and hyperperfusion clinical article. J Neurosurgery-Pediatrics. 2010;6(1):73–81.CrossRef Hayashi T, Shirane R, Fujimura M, Tominaga T. Postoperative neurological deterioration in pediatric moyamoya Disease: watershed shift and hyperperfusion clinical article. J Neurosurgery-Pediatrics. 2010;6(1):73–81.CrossRef
45.
Zurück zum Zitat Weimann J, Bauer H, Bigatello L, Bloch KD, Martin E, Zapol WM. ABO blood group and inhaled nitric oxide in acute respiratory distress syndrome. Lancet. 1998;351(9118):1786–7.PubMedCrossRef Weimann J, Bauer H, Bigatello L, Bloch KD, Martin E, Zapol WM. ABO blood group and inhaled nitric oxide in acute respiratory distress syndrome. Lancet. 1998;351(9118):1786–7.PubMedCrossRef
Metadaten
Titel
ABO blood types may affect transient neurological events after surgical revascularization in patients with moyamoya disease: a retrospective single center study
verfasst von
Mei-Ping Qian
Mei-Rong Dong
Ming-Ming Han
Juan Li
Fang Kang
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
BMC Anesthesiology / Ausgabe 1/2023
Elektronische ISSN: 1471-2253
DOI
https://doi.org/10.1186/s12871-023-02385-6

Weitere Artikel der Ausgabe 1/2023

BMC Anesthesiology 1/2023 Zur Ausgabe

Eingreifen von Umstehenden rettet vor Erstickungstod!

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.